Aprea Therapeutics
APRE
$5.27
Share price
-3.48%
Change (1 day)
37.24%
Change (1 year)
Categories
Aprea Therapeutics (APRE) - Cash on Hand
Cash on Hand as of December 2023 : $21.6 M
According to Aprea Therapeutics's latest financial reports the company has $21.6 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Aprea Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $28.78 M | -45.76% |
| 2021-12-31 | $53.07 M | -40.38% |
| 2020-12-31 | $89.01 M | -31.57% |
| 2019-12-31 | $0.13 B | 98.08% |
| 2018-12-31 | $65.67 M | 169.15% |
| 2017-12-31 | $24.4 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Magellan Health
MGLN | N/A | N/A | 🇺🇸 USA |
 Amedisys AMED | $0.10 B | 400.93% | 🇺🇸 USA |
 Healthcare Services Group HCSG | $0.10 B | 385.52% | 🇺🇸 USA |